Search Within

Janine Dellin Pichardo

Formats
  1. Meeting Abstract (32)
  2. Journal Article (8)
  3. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (38)
  2. Center for Hematologic Malignancies (33)
  3. Department of Medicine (33)
  4. Hematologic Malignancies, Division of (33)
  5. Executive Committee, Center for Hematologic Malignancies (21)
  6. Lymphoma (20)

More Groups

People
  1. Ahmet Dogan (35)
  2. Anas Younes (16)
  3. Andrew Zelenetz (16)
  4. Mikhail Roshal (13)
  5. Maria Arcila (11)
  6. Craig Moskowitz (9)

More People

Years
  1. 2020 (3)
  2. 2019 (4)
  3. 2018 (10)
  4. 2017 (6)
  5. 2016 (6)
  6. 2015 (7)

More Years

Publications
  1. Modern Pathology (12)
  2. Blood (11)
  3. Laboratory Investigation (7)
  4. Blood Cancer Journal (3)
  5. Applied Immunohistochemistry & Molecular Morphology (1)
  6. Blood Advances (1)

More Publications

Publishers
  1. American Society of Hematology (12)
  2. Nature Research (12)
  3. Nature Publishing Group (11)
  4. American Association for Cancer Research (1)
  5. Elsevier Ltd (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (41)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms
    Journal Article

    Gao, Q.; Yellapantula, V.; Fenelus, M.; Pichardo, J.; Wang, L.; Landgren, O.; Dogan, A.; Roshal, M.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
    Journal Article

    Intlekofer, A. M.; Joffe, E.; Batlevi, C. L.; Hilden, P.; He, J.; Seshan, V. E.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, C. H.; Portlock, C.; more...
    Blood Cancer Journal (2018)

    Fulltext@MSK | Save
  • MHC class II transactivator (CIITA) abnormalities are frequent in B-cell lineage lymphomas and are associated with loss of MHC class II (MHCII)
    Meeting Abstract

    Jelloul, F. Z.; Pichardo, J. D.; Khattar, P.; Ananthamurthy, A.; Rao, M.; Areeyqur, R.; Jungbluth, A.; Wang, L.; Zhang, Y.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Extramedullary plasmablastic transformation of plasma cell myeloma: Clinicopathologic study of 10 cases
    Meeting Abstract

    Jelloul, F. Z.; Bhavsar, T.; Pichardo, J. D.; Yabe, M.; Rao, M.; Zhang, Y.; Dogan, A.; Xiao, W.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • t(14;18) negative inguinal follicular lymphoma is characterized by genetic abnormalities of 1p36/TNFRSF14 and 16p/CREBBP regions
    Meeting Abstract

    Khattar, P.; Pichardo, J. D.; Jelloul, F. Z.; Robert, C.; Areeyqur, R.; Rao, M.; Zhang, Y.; Arcila, M.; Wang, L.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Hairy cell leukemia expresses programmed death 1 (PD-1): A new diagnostic marker
    Meeting Abstract

    Kumar, P.; Pichardo, J. D.; Lewis, N.; Chan, A.; Gao, Q.; Roshal, M.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • The histopathology of Erdheim-Chester disease: A comprehensive review of a molecularly characterized cohort
    Journal Article

    Ozkaya, N.; Rosenblum, M. K.; Durham, B. H.; Pichardo, J. D.; Abdel-Wahab, O.; Hameed, M. R.; Busam, K. J.; Travis, W. D.; Diamond, E. L.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Measurement of PD-1 expression on lymphoma cells by flow cytometry is a useful tool in diagnosing and monitoring minimal residual disease in angioimmunoblastic T-cell lymphoma
    Meeting Abstract

    Yabe, M.; Ozkaya, N.; Gao, Q.; Pichardo, J.; Huet, S.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • B-cell maturation antigen is exclusively expressed in a wide range of B-cell and plasma cell neoplasm and in a potential therapeutic target for BCMA directed therapies
    Meeting Abstract

    Khattar, P.; Pichardo, J.; Jungbluth, A.; Gao, Q.; Smith, E. L.; Roshal, M.; Dogan, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report
    Meeting Abstract

    Klimek, V. M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B.
    Leukemia Research (2017)

    Fulltext@MSK | Save